Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

LQDA

Liquidia (LQDA)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LQDA
DataOraFonteTitoloSimboloCompagnia
12/02/202523:34Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LQDALiquidia Corporation
23/01/202523:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LQDALiquidia Corporation
08/01/202514:00GlobeNewswire Inc.Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/11/202413:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LQDALiquidia Corporation
13/11/202412:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LQDALiquidia Corporation
13/11/202412:30GlobeNewswire Inc.Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
12/11/202414:00GlobeNewswire Inc.Liquidia to Present at the Stifel 2024 Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
06/11/202414:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024NASDAQ:LQDALiquidia Corporation
04/11/202414:00GlobeNewswire Inc.Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024NASDAQ:LQDALiquidia Corporation
18/10/202421:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LQDALiquidia Corporation
07/10/202416:00GlobeNewswire Inc.United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ PatentNASDAQ:LQDALiquidia Corporation
02/10/202412:00GlobeNewswire Inc.Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)NASDAQ:LQDALiquidia Corporation
30/09/202414:00GlobeNewswire Inc.Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual MeetingNASDAQ:LQDALiquidia Corporation
16/09/202415:41GlobeNewswire Inc.Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 MillionNASDAQ:LQDALiquidia Corporation
11/09/202422:41Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:LQDALiquidia Corporation
11/09/202414:29Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:LQDALiquidia Corporation
11/09/202414:26GlobeNewswire Inc.Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing AgreementNASDAQ:LQDALiquidia Corporation
28/08/202414:00GlobeNewswire Inc.Liquidia to Present at Upcoming Investor ConferencesNASDAQ:LQDALiquidia Corporation
22/08/202412:00GlobeNewswire Inc.Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
19/08/202412:00GlobeNewswire Inc.U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)NASDAQ:LQDALiquidia Corporation
16/08/202412:30GlobeNewswire Inc.Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific SessionsNASDAQ:LQDALiquidia Corporation
07/08/202412:30GlobeNewswire Inc.Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
31/07/202414:00GlobeNewswire Inc.Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:LQDALiquidia Corporation
08/07/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LQDALiquidia Corporation
18/06/202414:42GlobeNewswire Inc.Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)NASDAQ:LQDALiquidia Corporation
03/06/202413:00GlobeNewswire Inc.District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ LaunchNASDAQ:LQDALiquidia Corporation
29/05/202414:00GlobeNewswire Inc.Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:LQDALiquidia Corporation
13/05/202423:43GlobeNewswire Inc.Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LQDALiquidia Corporation
10/05/202414:00GlobeNewswire Inc.Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILDNASDAQ:LQDALiquidia Corporation
07/05/202414:30GlobeNewswire Inc.Liquidia Corporation to Present at BofA Securities Health Care Conference 2024NASDAQ:LQDALiquidia Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LQDA
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network